The Vero stereotactic body radiotherapy (SBRT) system, a cooperative partnership between Brainlab and Mitsubishi Heavy Industries, was introduced at the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) October 31 to November 4 in San Diego.

According to Feldkirchen, Germany-based Vero, the technology offers a combination of intensity modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT) and real-time tumor tracking in one treatment delivery system.